ARX:ASX
Aroa Biosurgery Ltd
0,50 AUD
arrow_downward
-1,96%(-0,0100) 1D
13 ნოე, 16:10:11 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 AUD
High
0,51 AUD
Low
0,50 AUD
Mkt. cap
172,95 მლნ.
Avg. vol.
266,66 ათ.
Volume
846,69 ათ.
P/E ratio
47,62
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
Open
0,50 AUD
High
0,51 AUD
Low
0,50 AUD
Mkt. cap
172,95 მლნ.
Avg. vol.
266,66 ათ.
Volume
846,69 ათ.
P/E ratio
47,62
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
News stories
From web sources and news partners
Seeking Alpha
·
24 წუთის წინ
uCloudlink Group Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:UCL) 2026-11-14
Crypto Briefing
·
8 წუთის წინ
Ava Labs says its NYSE deal cost nothing and opened doors with institutions
Yahoo Finance
·
1 საათის წინ
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
10 საათის წინ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd